Citizens Junkies has held its 'neutral' rating on Expensify stock after the US-based expense management software firm announced a share buyback programme. The decision to repurchase shares, revealed earlier this week, is seen by analysts as a signal that management believes the stock is undervalued and that the company has sufficient cash reserves to support the move.
Expensify, which provides cloud-based receipt tracking and expense reporting tools, has faced a challenging period as businesses tighten software spending amid higher interest rates. The buyback is intended to return capital to shareholders, but Citizens Junkies cautioned that the programme does not resolve the company's slowing subscription growth or the increasingly competitive landscape from rivals such as Concur and Zoho Expense.
For UK investors, the development is a reminder of how US-listed tech firms are deploying cash reserves to prop up share prices. While the buyback may provide short-term support for Expensify's stock, the company's revenue trajectory remains a concern. The broader SaaS sector has seen a shift in investor focus from growth at all costs to profitability and free cash flow generation.
Expensify shares have traded lower over the past 12 months as the company reported weaker-than-expected quarterly results. The buyback programme, while positive for sentiment, is not expected to reverse the trend unless accompanied by a sustained improvement in new customer additions and average revenue per user.
Analysts at Citizens Junkies highlighted that the firm's cash position remains healthy, which reduces the risk of financial distress. However, they noted that without a clearer path to accelerating top-line growth, the stock is likely to remain range-bound. The 'neutral' rating reflects this balanced view — neither overly bullish nor bearish on the near-term outlook.